Last updated on September 2016

(+) Epicatechin to Treat Friedreich's Ataxia

Brief description of study

This 24-week study will test the safety and effectiveness of synthetically produced (+) Epicatechin in treating patients who have Friedreich's Ataxia, a neurological disorder.

Clinical Study Identifier: NCT02660112

Contact Investigators or Research Sites near you

Start Over

Ralitza H. Gavrilova, MD

Mayo Clinic
Rochester, MN United States
  Connect »